Lenoss Medical’s spine biologic hits 150 cases

Advertisement

Lenoss Medical’s OsteoPearl procedure reached its 150th case, according to a March 27 news release shared with Becker’s.

More than half of the 150 cases were completed since September. OsteoPearl is an allograft designed to augment vertebral compression fractures. It provides a natural bone scaffold.

In 2024, Lenoss Medical closed $4 million in series A financing, and that money was used to accelerate commercialization. 

Advertisement

Next Up in Biologics

  • Healthcare solutions provider Summit Products Group, based in Dallas, has launched a strategic partnership with regenerative medicine developer NovaBone Products. …

  • From product launches and milestones, here are five updates in orthobiologics since March 28. 1. Lenoss Medical’s OsteoPearl procedure reached…

Advertisement